Recruiting
HIV prevention: WCS-HIV-7710
A Phase 3 study of a long-acting injectable given every six months for pre-exposure prophylaxis.
Home/Areas of Study/HIV
Join the research effort in HIV
Our HIV programme spans prevention, long-acting treatment and cure-directed research. Studies are designed with and for the communities most affected, because research that does not reach those communities does not answer the question.
40.8 million
people are living with HIV worldwide
24 studies in this area
Featured trials
A selection of what is open right now. Eligibility is decided by the investigator at a study site, never by this page.
Recruiting
HIV treatment: WCS-HIV-7744
A Phase 2 study of a long-acting regimen in participants already virologically suppressed on daily oral therapy.
Studies open and close continually. We can text you when a new one opens near you.
Get study alertsOur research
What are we studying?
Learn more about our areas of research and see whether one of our clinical trials might be right for you.
HIV prevention
- It is possible to prevent HIV transmission, and participants are helping test how far that can be pushed.
- Long-acting options matter most for people for whom a daily tablet is not realistic — which is a question about lives, not about adherence.
- Explore our prevention studies to see whether you may be eligible.
HIV treatment and cure-directed research
- Millions of people live long, healthy lives with HIV, but the work is not finished while treatment still means something taken every day for life.
- Treatment studies test regimens given weekly, monthly or less often.
- Cure-directed research asks whether the virus can be controlled without ongoing treatment at all.
Want to understand what taking part actually involves before you go further?
Read the guide